Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
1,646
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes

Lijuan Zhanga Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Kankan Chena Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Yingying Lia Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Qiuni Chena Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Wenting Shia Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Tingting Jia Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Hong Taoa Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Zhengmei Hea Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Chunling Wanga Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Liang Yua Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China;b Department of Hematology, The Huai’an Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China;c Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Article: 2181773 | Received 06 Apr 2022, Accepted 11 Feb 2023, Published online: 09 Mar 2023

References

  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Hasserjian RP. Myelodysplastic syndrome updated. Pathobiology. 2019;86(1):7–13.
  • Zahid MF, Malik UA, Sohail M, et al. Cytogenetic abnormalities in myelodysplastic syndromes: an overview. Int J Hematol Oncol Stem Cell Res. 2017;11(3):231–239.
  • Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241–247.
  • Peller S, Rotter V. TP53 in hematological cancer: low incidence of mutations with significant clinical relevance. Hum Mutat. 2003;21(3):277–284.
  • Horiike S, Kita-Sasai Y, Nakao M, et al. Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome. Leuk Lymphoma. 2003;44(6):915–922.
  • Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616–3627. quiz 3699.
  • Ok CY, Patel KP, Garcia-Manero G, et al. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. J Hematol Oncol. 2015;8:45.
  • Kulasekararaj AG, Smith AE, Mian SA, et al. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis. Br J Haematol. 2013;160(5):660–672.
  • Sallman DA, Komrokji R, Vaupel C, et al. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes. Leukemia. 2016;30(3):666–673.
  • Gu S, Xia J, Tian Y, et al. A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS. BMC Cancer. 2021;21(1):134.
  • Kulasekararaj AG, Smith AE, Mian SA, et al. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis. Br J Haematol. 2013;160(5):660–672.
  • Yan X, Wang L, Jiang L, et al. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer Med. 2021;10(5):1759–1771.
  • Ren Y, Mei C, Ye L, et al. Analysis of clinical and molecular features of MDS patients with complex karyotype in China. Blood Cells Mol Dis. 2019;75:13–19.
  • Hunter AM, Sallman DA. Targeting TP53 mutations in myelodysplastic syndromes. Hematol Oncol Clin North Am. 2020;34(2):421–440.
  • Ren Y, Wang J, Zhang H, et al. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype. Asia Pac J Clin Oncol. 2020;16(3):172–179.
  • Welch JS, Petti AA, Miller CA, et al. TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes. N Engl J Med. 2016;375(21):2023–2036.
  • Grove CS, Vassiliou GS. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? Dis Model Mech. 2014;7(8):941–951.
  • Wang H, Wang X, Xu X, et al. Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes. Ann Hematol. 2010;89(7):671–679.
  • Shi ZX, Qin TJ, Xu ZF, et al. Mean corpuscular volume ≤100fl was an independent prognostic factor in patients with myelodysplastic syndrome and bone marrow blast<5 percent. Zhonghua Xue Ye Xue Za Zhi. 2020;41(1):28–33.
  • Hunter AM, Komrokji RS, Yun S, et al. Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood Adv. 2021;5(4):1017–1028.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.